Pyrazinamide labels and packages: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pyrazinamide }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIK...")
 
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}


==Storage==
Store in a well-closed container at controlled room temperature 15°-30°C (59°-86°F).
Dispense in a well-closed container with a child resistant closure.
CAUTION: Federal law prohibits dispensing without prescription.
Marketed by:
EFFCON LABORATORIES, INC.
Marietta, GA 30065-1509
Manufactured by:
MIKART, INC.,
Atlanta, GA 30318
Rev. 8/94
Code 590A00





Revision as of 02:13, 4 January 2014

Pyrazinamide
PYRAZINAMIDE® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Storage

Store in a well-closed container at controlled room temperature 15°-30°C (59°-86°F).

Dispense in a well-closed container with a child resistant closure.

CAUTION: Federal law prohibits dispensing without prescription.

Marketed by:

EFFCON LABORATORIES, INC.

Marietta, GA 30065-1509

Manufactured by:

MIKART, INC.,

Atlanta, GA 30318

Rev. 8/94

Code 590A00



[1]


References

  1. "PYRAZINAMIDE (PYRAZINAMIDE) TABLET [MIKART, INC.]".

Adapted from the FDA Package Insert.